Nyxoah Stock (NASDAQ:NYXH)
Previous Close
$1.55
52W Range
$1.26 - $6.88
50D Avg
$1.55
200D Avg
$3.08
Market Cap
$149.11M
Avg Vol (3M)
$286.00K
Beta
0.96
Div Yield
-
NYXH Company Profile
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.